fenofibrate has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben, LH; Drew, PD; Gocke, AR; Hussain, RZ; Lovett-Racke, AE; Peng, H; Racke, MK; Stuve, O; Weiner, J; Yang, Y | 1 |
| Chavis, JA; Choy, J; Diab, A; Drew, PD; Hussain, RZ; Lovett-Racke, AE; Matthes, L; Northrop, S; Racke, MK; Rocchini, A | 1 |
2 other study(ies) available for fenofibrate and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease.
Topics: Animals; Blotting, Western; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Fenofibrate; GATA3 Transcription Factor; Gemfibrozil; Gene Expression Regulation; Immunologic Factors; Interleukin-4; Interleukin-5; Mice; Mice, Transgenic; PPAR alpha; Promoter Regions, Genetic; T-Box Domain Proteins; Transcription, Genetic; Transfection | 2009 |
Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease.
Topics: Animals; Cell Line; Cell Line, Transformed; Cell Survival; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Fenofibrate; Gemfibrozil; Growth Inhibitors; Humans; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbodies; Microglia; Nitric Oxide; Receptors, Cytoplasmic and Nuclear; T-Lymphocyte Subsets; Th2 Cells; Transcription Factors | 2004 |